Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
350 participants in 2 patient groups
Loading...
Central trial contact
Hansel Tookes, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal